Check4Cancer integrates services to enable fast cancer screening

14 September 2020 (Last Updated September 14th, 2020 13:55)

Early cancer detection and genetic services provider Check4Cancer has launched its new brand and website to provide cancer screening services.

Check4Cancer integrates services to enable fast cancer screening
Check4Cancer offers screening and diagnostic services for six most prevalent cancers in the UK. Credit: Michal Jarmoluk / Pixabay.

Early cancer detection and genetic services provider Check4Cancer has launched its new brand and website to provide cancer screening services.

The new integrated service offers easier access to cancer screening and diagnostic tests for people concerned about cancer, particularly for those who missed appointments due to Covid-19 pandemic.

Check4Cancer offers screening and diagnostic services for the six most prevalent cancers in the UK, including breast, bowel, cervical, prostate, lung and skin cancers.

The new brand and website by the company will provide screening for four types of cancers available as at-home sample collection kits.

Check4Cancer chief medical officer Gordon Wishart said: “As always, Check4Cancer aims to help those worried about cancer. We are pleased to be able to continue to offer our full suite of services during this challenging time.

“Many of our tests can be carried out in the comfort of your own home. By offering all of our cancer screening services under one umbrella, this new online service will make it quick and easy for people to get tested. Early detection is key in our fight against cancer.”

It is said that the ongoing Covid-19 pandemic has considerably disrupted the cancer services in the UK with many people experiencing delays and cancellations to their usual GP and outpatient appointments.

According to Cancer Research UK, approximately 200,000 people a week have not been screened for breast, bowel and cervical cancer during the pandemic. Over 18,000 people are estimated to die due to cancer in the first 12 months of the pandemic.

In November 2018, Check4Cancer collaborated with AXA PPP healthcare to launch a new prostate cancer diagnosis pathway.